Silicone Scar Care Timeline Clinical Guide

Download PDF Version
Title

This clinical guide outlines the appropriate timing and duration of silicone therapy in scar management. It provides a structured framework aligned with biological healing phases, helping clinicians determine when silicone is indicated and how long therapy should continue.
 
Silicone is widely used in post-surgical and traumatic scar care. Appropriate initiation and realistic duration expectations are central to effective use.

Biological Context of Scar Healing

Scar formation progresses through overlapping phases:

 

• Inflammatory phase (immediate to ~1 week)

• Proliferative phase (~1–4 weeks)

• Remodelling phase (months to over a year)

 

Silicone therapy is typically introduced after full epithelialisation, during the early proliferative phase.

 

Its role is not to eliminate scars but to support modulation of collagen deposition and hydration within the scar environment.

Epithelialisation and Safe Initiation

Silicone should only be introduced once the wound has:
 
• Fully epithelialised
• No open areas
• No active drainage
• No signs of infection
 
Initiating silicone before full closure may compromise healing.

Typical Silicone Initiation Window

Most clinical frameworks suggest beginning silicone:

 

• Approximately 1–2 weeks post-closure (depending on wound type)

• Once sutures are removed (where applicable)

• After confirmation of complete epithelialisation

 

Earlier initiation does not necessarily improve outcomes and may reduce adherence if skin sensitivity is present.

Duration of Use

Silicone therapy typically continues for several months.

 

General guidance:

 

• Use daily as directed

• Continue through early remodelling phase

• Monitor thickness, erythema, and pliability

 

Scar maturation can extend beyond 12 months. Silicone use duration should reflect scar behaviour rather than arbitrary timelines.

Monitoring Response

Indicators of favourable response may include:
 

• Reduced redness

• Decreased firmness

• Flattening of raised areas

• Reduced pruritus

 

If progressive thickening or increasing symptoms occur, reassessment may be required.

 

Clinical Considerations

Silicone is most effective when:

 

• Initiated at appropriate biological timing

• Used consistently

• Combined with patient education

• Monitored over time

 

Adherence is often the limiting factor rather than product choice.

 

Scar Healing Timeline Diagram

Figure 1. Typical scar healing progression and approximate window for silicone initiation relative to epithelialisation and remodelling.

 

Key Principles

 

• Begin after full epithelialisation

• Align expectations with biological phases

• Emphasise consistency over intensity

• Monitor and reassess as needed

 

Clinician Notes

.
.
.
.
.
.